Skip NavigationSkip to Content

LC-MS/MS assay coupled with carboxylic acid magnetic bead affinity capture to quantitatively measure cationic host defense peptides (HDPs) in complex matrices with application to preclinical pharmacokinetic studies

  1. Author:
    O'Neill,Maura
    Chan,King
    Jaynes, Jesse M
    Knotts, Zachary
    Xu,Xia
    Abisoye-Ogunniyan, Abisola
    Guerin,Theresa
    Schlomer,Jerome
    Li, Dandan
    Cary, Jeffrey W
    Rajasekaran, Kanniah
    Yates, Clayton
    Kozlov,Serguei
    Andresson,Thorkell
    Rudloff, Udo
  2. Author Address

    Protein Characterization Laboratory, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research Inc., Frederick, MD, USA., Integrative Biosciences Center, Tuskegee University, Tuskegee, AL, USA., Rare Tumor Initiative, Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA., Integrative Biosciences Center, Tuskegee University, Tuskegee, AL, USA; Thoracic and GI Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA., Center for Advanced Preclinical Research, Center for Cancer Research, National Cancer Institute, Frederick, MD, USA., United States Department of Agriculture, Southern Regional Research Center, New Orleans, LA, USA., Protein Characterization Laboratory, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research Inc., Frederick, MD, USA. Electronic address: andressont@mail.nih.gov., Rare Tumor Initiative, Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA. Electronic address: rudloffu@mail.nih.gov.,
    1. Year: 2020
    2. Date: Mar 20
    3. Epub Date: 2020 01 02
  1. Journal: Journal of pharmaceutical and biomedical analysis
    1. 181
    2. Pages: 113093
  2. Type of Article: Article
  3. Article Number: 113093
  4. ISSN: 0731-7085
  1. Abstract:

    Synthetic host defense peptides (HDP) are a new class of promising therapeutic agents with potential application in a variety of diseases. RP-182 is a lOmer synthetic HDP design, which selectively reduces M2-like tumor associated macrophages via engagement with the cell surface lectin receptor MRC1/CD206 and is currently being developed as an innate immune defense regulator to improve anti-tumor immunity in immunologically cold tumors. Herein, we describe a sensitive and specific liquid chromatography (LC) coupled to quadrupole electron spray tandem mass spectrometry method to measure positively charged HDPs and HDP peptide fragments in complex biological matrices. Carboxylic acid magnetic beads were used as an affinity-capturing agent to extract the positively charged RP-182 from both mouse plasma and tissue homogenates. Beads were eluted with 0.1% (v/v) formic acid and chromatographic separation was achieved on a Waters 2.1 x 100 mm, 3.5 mu m XSelect Peptide CSH C18 column with a Vanguard precolumn of the same phase. MS/MS was performed on a Thermo TSQ Quantiva triple quadrupole mass spectrometer operating in Selected Reaction Monitoring (SRM) mode fragmenting the plus three parent ion 458.9(+3) and monitoring ions 624.0(+2), 550.5(+2), and 597.3(+1) for RP-182 and 462.4(+3) > 629.1(+2), 555.5(+2), and 607.3(+1) for isotopic RP-182 standard. The assay had good linearity ranging from 1 ng to 1000 ng in mouse plasma with the lower limit of detection for RP-182 at 1 ng in mouse plasma with good intra- and inter-sample precision and accuracy. Recovery ranged from 66% to 77% with minimum matrix effects. The method was successfully applied to an abbreviated pharmacokinetic study in mice after single IP injection of RP-182. The method was successfully tested on a second HDP, the 17mer D4E1, and the cationic human peptide hormone ghrelin suggesting that it might be a general sensitive method applicable to quantifying HDP peptides that are difficult to extract. Published by Elsevier B.V.

    See More

External Sources

  1. DOI: 10.1016/j.jpba.2020.113093
  2. PMID: 31931447
  3. WOS: 000516107400010
  4. PII : S0731-7085(19)31289-0

Library Notes

  1. Fiscal Year: FY2019-2020
NCI at FrederickClose Button

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel